The expression level of HIF‐1α in the bone marrow tissues of MDS was not statistically significant in relation to clinicopathologic parameters, such as WHO classification, IPSS scores, karyotype prognosis, and the cell type (Table 1, Figure 4). The gene discussed is HIF1A; the disease is myelodysplastic syndrome.